Queva Christophe 4
4 · Oncorus, Inc. · Filed May 26, 2021
Insider Transaction Report
Form 4
Oncorus, Inc.ONCR
Queva Christophe
CSO and SVP, Research
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-05-24−35,561→ 17,781 totalExercise: $1.81Exp: 2028-11-13→ Common Stock (35,561 underlying) - Exercise/Conversion
Common Stock
2021-05-24$1.81/sh+35,561$64,365→ 71,181 total
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vested on September 9, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.